Search Results
Slidesets
First line therapies: implications for long term resistance - Anne-Geneviève Marcelin, MD
Presented at:
European Meeting on HIV & Hepatitis 2019
Slidesets
Achieving SVR in CTP C – MELD Purgatory - Christophe Duvoux, MD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Slidesets
Clinical Development of Long-Acting Broadly Neutralizing Monoclonal Antibodies: Lessons Learned Thus Far- Richard Koup, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
HIV and adolescents: How do we help them to prepare for adult lifeation?- Rangsima Lolekha
Presented at:
APACC 2017
Slidesets
The Effectiveness of Treatment for Chronic Hepatitis C (and Hepatitis B) in Pediatric Populations- Manal El-Sayed, MD, PhD
Presented at:
HEP DART 2017
Abstracts
Growth recovery among Asian children with perinatally acquired HIV infection on first-line combination antiretroviral therapy
T. Sudjaritruk
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Slidesets
Introduction to Birth Dose Vaccination - Julien Kabore, DDS, MPH
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Slidesets
Framework for Drug Resistance and Drug Resistance Related Issues - Fengting Yu
Presented at:
The 3rd International Forum on HIV Treatment and Prevention in Asia-Pacific Region